1997 …2024

Research activity per year

Personal profile


Ian Glaspole performs translational and clinical research in interstitial lung diseases, such as idiopathic pulmonary fibrosis. He is the director of the Interstitial Lung Disease Clinic at the Alfred Hospital, Melbourne. He is an adjunct clinical associate professor of medicine at Monash University’s School of Translational Medicine.

A/Prof Glaspole has maintained a strong research focus since completing his PhD, within which he studied the human cellular immune response to nut allergens. Since then, his research has focused on interstitial lung disease, and has included numerous clinical trials exploring treatments for idiopathic pulmonary fibrosis, along with other clinical and laboratory based research, principally focused on improving the symptoms and quality of life of sufferers of these rare lung diseases.

His research is funded by the NHMRC, and philanthropic and industry sources. He serves on advisory boards and steering committees for clinical trials in idiopathic pulmonary fibrosis (IPF) and other forms of lung fibrosis. He is the co-chair of the Australian IPF Registry, and a steering committee member of the Centre for Research Excellence in Pulmonary Fibrosis.

A/Prof Glaspole is a member of the Thoracic Society of Australia & New Zealand, the Australian Society of Clinical Immunology and Allergy, and the Australian Sleep Association.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Research area keywords

  • Interstitial lung disease